Published in

American Medical Association, JAMA Neurology, 9(75), p. 1114, 2018

DOI: 10.1001/jamaneurol.2018.0894

Links

Tools

Export citation

Search in Google Scholar

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO